Liquid Chromatography Master Class

Manage webcast
Professor Peter Schoenmakers and Dr Lee Polite
This webinar will consist of 2 parts:

1. Answers to your questions asked in Professor Schoenmakers' Introduction to Liquid Chromatography webinar.

2. An interactive Q&A session for Dr Polite's "Resolution in Liquid Chromatography" video tutorial.

Chromedia, for a limited time only, will provide Dr Lee Polite's video tutorial Resolution in LC available completely for free!
Feb 17 2010
60 mins
Liquid Chromatography Master Class
More from this community:

Forensic Science

  • Live and recorded (243)
  • Upcoming (3)
  • Date
  • Rating
  • Views
  • RNAi screening has made it possible to identify new genes, or gene networks, that are involved in a wide vari¬ety of biological processes, including assays relevant to signal transduction, cell viability, cell morphology, protein localization and function, drug resistance, and responses of host cells to pathogens. As such, RNAi continues to help us gain critical insights into the mechanisms underlying human disease and accelerate the development of treatments for cancer and a host of other disorders. The intersection between RNAi screening and complementary approaches such as CRISPR-Cas9-mediated genome editing has opened up new opportunities for assay development, screening and validation. The successful implementation of genome-editing technologies in several species suggests this will serve as an important and relevant tool for validation studies in numerous cell lines and model systems. Additionally, RNAi rescue experiments using LentiORFs serve an important role in further validating and boosting confidence of screened hits. As we continue to develop new strategies to improve genome-wide RNAi screening and validation, the significance of RNAi as a research tool will remain for many years to come.
  • Computer Aided Synthetic Design: How ARChem Can Improve Your Efficiency and Creativity

    Are you looking for a better way to synthesize a target molecule?

    Have you hit a roadblock in the lab or need an extra burst of creative thinking?

    Join Orr Ravitz at 10:00 AM (EDT) on July 16th for an overview of the future of synthetic design and the software that can help improve your efficiency and creativity in the lab with ARChem.

    He will discuss how medicinal chemists, process chemists and material scientists use ARChem as an idea generator – a tool for route scouting, for brain storming sessions, for the daily synthesis planning and potentially provide an alternative that gets you to curated experimental pathways faster than exploring the literature.

    This webinar will cover:

    ◦The technology behind ARChem and real life case studies
    ◦How ARChem can improve your productivity and creativity in the lab
    ◦Future developments of our synthetic design software
  • RNAi screening has made it possible to identify new genes, or gene networks, that are involved in a wide vari¬ety of biological processes, including assays relevant to signal transduction, cell viability, cell morphology, protein localization and function, drug resistance, and responses of host cells to pathogens. As such, RNAi continues to help us gain critical insights into the mechanisms underlying human disease and accelerate the development of treatments for cancer and a host of other disorders. The intersection between RNAi screening and complementary approaches such as CRISPR-Cas9-mediated genome editing has opened up new opportunities for assay development, screening and validation. The successful implementation of genome-editing technologies in several species suggests this will serve as an important and relevant tool for validation studies in numerous cell lines and model systems. Additionally, RNAi rescue experiments using LentiORFs serve an important role in further validating and boosting confidence of screened hits. As we continue to develop new strategies to improve genome-wide RNAi screening and validation, the significance of RNAi as a research tool will remain for many years to come.
  • Understanding your customers is fundamental to effective communication. Current segmentation strategies draw on ever more detailed information about how patients, physicians and payers behave through the use of open source, social media and real world data. However, segmentation still lacks clear insight into why these stakeholders behave as they do – and therefore how best to change their behaviour.
    Working with behavioural change experts Hamell, this one hour live discussion will look at why current segmentation strategies are failing, and the importance of understanding what drives patient or customer behaviour. Using case studies, speakers will explore how segmenting by behavioural drivers can create advanced, effective strategies to change patient, customer and payer behaviour.
    This event will focus on three key areas:

    •The theory behind behavioural segmentation and how it challenges the status quo
    •Benefits of behavioural segmentation communication strategies and the problems answered by behavioural segmentation strategies
    •Behavioural segmentation in action: practical application of this approach
  • Life sciences companies need to make better use of the insights that real world data (RWD) can provide in order to improve market access, sales and market growth strategies – and ultimately to improve the applicability of new and existing therapeutics for patients. Insights come not just from the multiple sources of RWD available, but from advanced analytics that highlight the effectiveness of a treatment by geographic area, and link healthcare providers, institutions and patients to relevant and meaningful outcomes.

    This one-hour event will take a hands-on approach – detailing how insights derived from RWD (and collaboratively with other sources) are enabling all elements of the life science industry to do things better.

    Insights experts Robin Munro and Christian Marcazzo will deliver case studies on how RWD can help life science companies in:

    Sales and Marketing – incorporate RWD and evidence into segmentation, targeting, and engagement of physicians and institutions
    Commercial Effectiveness – measure commercial campaigns, and demonstrate the impact to the healthcare system
    Medical Affairs – find and engage medical education prospects and target appropriate healthcare authorities, healthcare professionals and payers, to improve quality of care and outcomes
    Public Affairs and Market Access – develop qualitative and quantitative insights to design education, advocacy and access-related campaigns within the healthcare ecosystem

    The event will also give an exclusive look at what can be achieved from combining data sources – using Diabetes in England as a case study, Zephyr has implemented novel methods to demonstrate an evidence-based approach to improving information sharing within sales teams and to engaging accounts and payers. We explore how patient outcomes from RWD can add value to commercial strategy.
  • Cell lines remain the workhorses of laboratory research, both in academic and industrial settings. This webinar will focus on best practice in selecting and maintaining cell lines for research, to ensure research outputs are relevant and reproducible. Features of cell lines that might be used in selection will be discussed. This will include monolayer or suspension culture; passage number; doubling time; immortalisation; karyotype; receptors; expression profiling and use of bioinformatics tools like the cancer cell line encyclopaedia. Using breast cancer as an exemplar, I will discuss more specifically how to choose the most relevant cell line model to address a particular research question. Finally I will describe how to use (and access) human material to help develop more clinically relevant cell culture systems to model human disease and the role that biobanks play in this process.
  • Cell lines remain the workhorses of laboratory research, both in academic and industrial settings. This webinar will focus on best practice in selecting and maintaining cell lines for research, to ensure research outputs are relevant and reproducible. Features of cell lines that might be used in selection will be discussed. This will include monolayer or suspension culture; passage number; doubling time; immortalisation; karyotype; receptors; expression profiling and use of bioinformatics tools like the cancer cell line encyclopaedia. Using breast cancer as an exemplar, I will discuss more specifically how to choose the most relevant cell line model to address a particular research question. Finally I will describe how to use (and access) human material to help develop more clinically relevant cell culture systems to model human disease and the role that biobanks play in this process.
  • The way that physicians want and need to consume information is changing, almost to the point of being unrecognisable from the tried and tested methods of yesteryear, Working in conjunction with Ashfield Healthcare this event brings together Medical Futurist Dr Bertalan Meskó, Dr Partha Kar, Consultant Endocrinologist, Portsmouth Hospitals NHS Trust, with Ruth Herman and Nigel Campbell of Ashfield, which recently launched the Medical Education Future Forum and will be presenting insights from this unique programme.

    Taking place on the 21st May at 12.30 (UK), 13.30 (EU), 07.30 (E. US) and moderated by pharmaphorum's CEO Paul Tunnah, the debate will centre on three key questions,

    Why and how are physicians changing the way they receive information?
    What are the trends and technologies shaping the landscape of medical communication?
    What are the implications of this for pharma (with examples)?
  • Improve Your Mass Spectrometry Workflows With the New NIST Software, Featuring the Wiley 10th/NIST 2014

    Hosted by Prof David Sparkman

    Release 2.2 is one of the most significant improvements in NIST’s MS Search software. Prof Sparkman will lead an online webinar providing insight into the latest improvements in the most popular mass spectrometry program on the planet, with insights into how you can improve and speed up your analyses by using the full suite of functions available in MS Search 2.2 and the power of using these with the broadest compound coverage available.
    -Compatibility and systems interface tips
    -Retention time workflow
    -LCMSn workflow
    -Accurate mass workflow
    -Search strategies
    -Compound coverage strategies
  • Regardless of the colour of the next UK government that emerges as a result of the May election, the £30-£50bn NHS budget chasm is the abyss that all the parties fear in respect of its thereat to quality health service delivery and re-election.

    With political backs to the abyss, no hostages will be taken. It is not unrealistic to expect a well co-ordinated and concerted offence by politicians and patient organisations alike on industry pricing of innovative speciality and rare diseases medicines:

    With this scenario in mind pharmaphorum is once again working with IMS Health to bring you expert insight into what this means for the UK health system and more specifically market access for specialist treatments in the post-election environment.

    Angela McFarlane, Senior principal IMS Health Local Market Access, Anthony Grosso, Principal Pharmacist at the National Hospital for Neurology and Neurosurgery and Sheela Upadhyaya, previously a NHS Senior Manager with over 17 years of experience in the delivery of services and in commissioning of highly specialised services for rare and ultra rare conditions, combine with pharmaphorum's Paul Tunnah to deliver an accurate analysis and frontline insight as to the already complex roadmap for access is about to change again.

    This one hour event will include analysis of informed predictions which include:

    The NICE HTA criteria will get tougher post end to end review (IMMTreV)
    NICE and the NHS England will join forces to streamline access pre/post NICE
    Risk at local level will be shifted to Providers under the new marginal tariff arrangements; which could indeed see a close to the CDF as the PbR excluded drugs list becomes a thing of a glorious past
    Provider baselines will take the strain of innovation - the tough decisions will be softened by a drive to really accelerate uptake of NICE approved medicines

    How can industry prepare for these changes in what is already a tough and complex environment?
  • Channel
  • Channel profile
  • Sports Drug Testing: Chromatography & Mass Spec-Based Approaches Recorded: Sep 9 2010 51 mins
    Professor Mario Thevis
    Doping control analysis predominantly utilises chromatography and mass spectrometry-based approaches to detect prohibited substances and methods of doping. These compounds and methods present both low and high molecular weight analytes of xenobiotic or natural / endogenous origin, which are to be detected, and occasionally quantified, using state-of-the-art instruments.

    The majority of the employed tools provides low resolving power. However, high resolution / high accuracy mass spectrometry has gained much attention recently due to: constantly increasing analytical requirements concerning the number of target compounds; the complexity of analytes (e.g. peptides and proteins); and the desire to accelerate analyses and obtain information (allowing for retrospective data mining).

    A selection of compounds, new challenges, and methods currently employed in doping control laboratories will be presented to the audience including, for example: new anabolic agents referred to as selective androgen receptor modulators (SARMs); insulins; so-called "releasing peptides" that stimulate the endogenous production of natural hormones; and ways of manipulating drug tests.
  • Introduction to Sample Preparation Recorded: Apr 21 2010 62 mins
    Professor Nicholas Snow
    Sample preparation is the most important, yet often most neglected area of chromatographic training and method development. The world's finest gas and liquid chromatographs generally cannot overcome mistakes made prior to sample injection.

    This webinar will focus on general principles of sampling and sample preparation for chromatography and an overview of key concepts for several major sample preparation techniques, including:

    * Liquid-liquid and liquid-solid extractions (LLE and LSE)
    * Static headspace extraction (SHE)
    * Solid phase extraction (SPE)
    * Sorptive micro-extractions (SPME and SBSE).

    Discussion will directed toward seeing the commonalities among all extraction techniques and toward choosing the best technique for a given analytical problem. Fundamentals of sample and glassware handling will also be reviewed.

    This webinar is directed toward analysts who use these techniques hands-on every day and to the laboratory managers who must teach, train and supervise them.
  • Liquid Chromatography Master Class Recorded: Feb 17 2010 60 mins
    Professor Peter Schoenmakers and Dr Lee Polite
    This webinar will consist of 2 parts:

    1. Answers to your questions asked in Professor Schoenmakers' Introduction to Liquid Chromatography webinar.

    2. An interactive Q&A session for Dr Polite's "Resolution in Liquid Chromatography" video tutorial.

    Chromedia, for a limited time only, will provide Dr Lee Polite's video tutorial Resolution in LC available completely for free!
  • Introduction to Liquid Chromatography Recorded: Jan 19 2010 51 mins
    Professor Peter Schoenmakers
    In this webinar, Professor Peter Schoenmakers will provide insight into the various LC techniques, including:

    * An overall perspective of current usage and applications of the various techniques.
    * A description of how the techniques developed, starting from paper chromatography up-to current "high tech" two-dimensional separations.
    * A more detailed focus on the concept of various methods.

    Often portrayed more as magic than science, popular television series such as CSI have aroused great interest in analytical chemistry. Forensic science relies on separation science.

    Peter Schoenmakers' webinar will also, in a light-hearted manner, put LC methods into the correct perspective for forensic science.
  • Introduction to Gas Chromatography Recorded: Oct 28 2009 52 mins
    Professor Harold McNair
    The first activity in the Year of Education is a series of free educational webinars, run in conjunction by separationsNOW and Chromedia. In the first webinar, Professor Harold McNair gives an interactive lecture on the basics of gas chromatography.

    This first webinar is intended for persons who:

    * Use chromatography and would like to revisit the basics of GC.
    * Have a little knowledge and would like to learn more!

    Some knowledge of general and organic chemistry is assumed. The webinar should prove useful to technicians, students, graduate students, PhDs and even professors planning to work with GC.

    Topics to be discussed are:

    * Definitions of GC
    * Separation principles
    * Advantages and limitations of GC
    * Basic instrumental components of a GC
    * Capillary columns
    * Three detectors: FID,TCD and ECD
brought to you by separationsNOW.com (Wiley-Blackwell) and Chromedia
The Year of Education came about through discussions between 3 professors who actively teach chromatography:

* Professor Harold McNair, Virginia Tech, Blacksburg, USA
* Professor Pat Sandra, University of Ghent, Belgium
* Professor Peter Schoenmakers, University of Amsterdam, Netherlands

"The first activity is a free webinar on gas chromatography, followed by a number of other activities, more webinars, online short courses, tutorials, instruction videos and much more! 2010 will be a year full of activities.

Many experts will be involved, from university and industry. We believe all chromatographers should actively take part in this: in teaching, telling their employees and students to take courses. This is a chance they should not miss!"

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Liquid Chromatography Master Class
  • Live at: Feb 17 2010 4:00 pm
  • Presented by: Professor Peter Schoenmakers and Dr Lee Polite
  • From:
Your email has been sent.
or close
You must be logged in to email this